Stock·NYSE·Technology
Salesforce, Inc. (CRM)
- Market cap
- $198.10B
- P/E
- 22.76
- Dividend yield
- 0.72%
- Street target
- $285.00median of 56 analysts
- 52-week range
- $146.32 $269.11
The short version
Where CRM stands today, in four lines, and what CleaRank Financial AI makes of it.
CRM at a glance
Salesforce, Inc. (CRM): Buy, 78/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($230.12 and $199.05).
- Earnings CRM beat estimates in 7 of its last 8 quarters, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $88.8M and bought $28.4M over the last 18 months.
- Valuation P/E of 22.8 against 35.1 for the Technology sector: a discount to peers (-35%).
Figures as of October 16, 2026.
CleaRank Financial AI
CleaRank rates Salesforce, Inc. (CRM) Buy with a model score of 78/100.
Trend adds the most to that score: the price is 20.92% above its 200-day average and 4.60% above its 50-day average, and the 50-day average is 15.61% above the 200-day. Revenue growth pulls hardest in the other direction, since revenue grew 10.80%, 13.4 percentage points slower than the sector median. The 50-day average sits at $230.12 and the 200-day at $199.05, and over the past year the price fell 2.15%.
Only on CleaRank
Figures we compute ourselves from CRM's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $240.70 is 4.6% above the 50-day simple moving average of $230.12.Price above its 200-day average ›
The price is 20.9% above the 200-day simple moving average of $199.05.50-day average above the 200-day ›
The 50-day average ($230.12) is 15.6% above the 200-day average ($199.05), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 77% of its 52-week range, between $146.32 and $269.11.
CRM share price
Pick a period: each tab shows how far CRM has moved over it, to the last close.
Today's trading
Where CRM sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 22.76 is 35.2% below the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 4.62 is 39.2% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $9.7B on revenue of $43.9B, a net margin of 22.0%.Beat estimates in most recent reports ›
CRM beat the EPS estimate in 7 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 0.72%, or $1.74 a share a year.
Key statistics
The headline figures for CRM.
As of October 16, 2026, CRM trades at $240.70, with a market value of $198.10B, a P/E ratio of 22.76 and a dividend yield of 0.72%.
What the numbers say
CleaRank Financial AI's reading of CRM's valuation, growth and risks.
Salesforce, Inc. (CRM) has a trailing P/E of 22.76, which is 35.2% below the Technology sector median of 35.1. The Peer Benchmarking card reads this as a discount to peers. On sales, CRM trades at 4.62 times, 39.2% below the sector median of 7.6. Its market capitalisation stands at $198.1B, and trailing earnings are $10.84 a share.
CRM is growing revenue at 10.80%, which leaves it 13.4 percentage points slower than the sector median of 24.2%. Still, each unit of sales turns into profit at a net margin of 21.99% and an operating margin of 21.38%. Return on equity reaches 19.38%, which is above the sector median of 13.4%. On the balance sheet, debt-to-equity stands at 1.10, and the trailing dividend yield of 0.72% works out to $1.74 a share each year.
The August 26, 2026 report was a beat: EPS of $5.90 compared with the $3.27 that analysts expected, a margin of 80.43%. In the next session, the shares climbed 22.58%.
CRM has topped the EPS estimate in 7 of its last 8 reports, yet the stock fell after 4 of those 7 beats in the session that followed. Further back, the share price rose 4.03% after the February 25, 2026 report, which beat the estimate by 24.92%. Analysts forecast EPS of $16.75 for this fiscal year, a gain of 33.8%, and $16.02 for the next, a decline of 4.4%.
Day-to-day swings are the main thing to plan around, since CRM has moved 2.21% on an average session. Over the last 18 months, insiders sold $88.8M of stock and bought $28.4M. Sales of this kind are often planned in advance, so they carry less weight than purchases, which signal more.
CRM against the Technology sector
How CRM compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: CRM trades at a notable discount to sector peers (-35%), which may indicate undervaluation or specific company headwinds.
Return vs XLK: Since May 6, 2025, CRM has lost 12.0% against a gain of 73.7% for XLK.
Performance against XLK
CRM and the Technology sector fund over the same days.
Revenue and earnings
How much CRM sells, and how much of it becomes profit.
Revenue growth: Revenue grew 9.6% in FY2026 to $41.5B, from $37.9B a year earlier.
Profit margin: The net margin was 18.0% in FY2026, up from 16.4% the year before.
Profitable: CRM earned $7.5B in FY2026.
Earnings reality check
Did CRM beat what analysts expected, and how did the stock react?
Earnings record: CRM beat the analyst estimate in 7 of the last 8 quarters.
Market reaction: The stock fell in the first session after 4 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 26, 2026after close | $3.27 | $5.90 | +80.43% | +22.58% | +24.95% |
| May 27, 2026after close | $3.13 | $3.88 | +23.96% | -0.75% | +7.38% |
| Feb 25, 2026after close | $3.05 | $3.81 | +24.92% | +4.03% | +0.69% |
| Dec 3, 2025after close | $2.86 | $3.25 | +13.64% | +3.66% | +10.67% |
| Sep 3, 2025after close | $2.78 | $2.91 | +4.68% | -4.85% | -5.41% |
| May 28, 2025after close | $2.55 | $2.58 | +1.18% | -3.30% | -4.66% |
| Feb 26, 2025after close | $2.61 | $2.78 | +6.51% | -4.04% | -5.00% |
| Dec 3, 2024after close | $2.45 | $2.41 | -1.63% | +10.99% | +5.25% |
As of October 16, 2026, CRM has beaten the analyst EPS estimate in 7 of its last 8 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on August 26, 2026, came in 80.43% above the estimate and the stock moved +22.58% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 55.8, in neutral territory.RSI above 50 ›
An RSI of 55.8 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of CRM
The score, the reasoning behind it, and what could move the price next.
Salesforce, Inc. (CRM) is still in an uptrend, with the stock at $240.70. It sits 4.60% above its 50-day average of $230.12 and 20.92% above its 200-day average of $199.05. Within its 52-week range, the price is 10.56% below the high of $269.11 and 64.50% above the low of $146.32, which places it near the top of that band.
The short and long run point different ways: the price fell 3.93% over the past month, rose 40.95% over the past three months and fell 2.15% over the past year. The 14-day RSI of 55.8 is in the neutral zone, and the MACD line is positive.
Earnings beat ›
The August 26, 2026 report beat the EPS estimate by 80.43%, and the share price rose 22.58% in the first session after it.
Source: Earnings report, August 26, 2026Analyst upgrade ›
B of A Securities upgraded it to Buy from Underperform on October 12, 2026.
Source: Analyst action, B of A Securities, October 12, 2026
No risks flagged.
- Keep an eye on the two nearest levels: the 52-week high of $269.11 above the price, and the 20-day EMA at $235.05 below it.
- The 14-day RSI reads 55.8, in the neutral zone, with the MACD line positive; readings above 70 or below 30 mark stretched momentum.
- The share price rose 22.58% in the first session after the August 26, 2026 report. CRM has beaten estimates in 7 of the last 8 reports.
CRM's uptrend depends on the price holding above its 50-day average of $230.12 and its 200-day average of $199.05. A close below the 50-day average would be the first sign of that trend weakening. If the price pulls back, the 20-day EMA at $235.05 is the first level it would reach.
Overhead, the next level the price would meet on the way up is the 52-week high of $269.11.
Technical indicators
Momentum and trend for CRM, from its daily closes.
As of October 16, 2026, with CRM at $240.70, its 14-day RSI is 55.8 (neutral territory), its 50-day simple moving average is $230.12 and its 200-day is $199.05.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What CRM moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, CRM's 1-year correlation of daily returns is +0.37 with S&P 500 (SPY), +0.31 with Nasdaq 100 (QQQ), +0.16 with Bitcoin (BTC) and -0.04 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
40 of 56 analysts rate it a buy or strong buy, 15 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $285.00 is 18.4% above the price.More buy ratings than three months ago ›
40 of 56 rate it a buy now, against 40 of 55 three months ago.
CRM Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2026 | B of A Securities | Upgrade | Buy |
| Sep 18, 2026 | Citizens | Reiterates | Market Outperform |
| Sep 18, 2026 | Stephens & Co. | Reiterates | Equal-Weight |
| Sep 18, 2026 | Wells Fargo | Maintains | Equal-Weight |
| Sep 17, 2026 | Freedom Broker | Maintains | Buy |
| Sep 17, 2026 | Stifel | Maintains | Buy |
As of October 16, 2026, 56 Wall Street analysts cover CRM: 40 rate it a buy or strong buy, 15 a hold and 1 a sell or strong sell. Their 12-month price targets range from $165.00 to $475.00, with a median of $285.00, 18.4% above the price of $240.70.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CRM trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from CRM's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CRM tends to move, against the market and on its own.
The long record
CRM's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 2.21% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 58.5%, from November 2021 to December 2022, regained by March 2024.Most 1-year holds ended higher ›
69% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $34,523, against $42,525 in the S&P 500 (SPY).
CRM Drawdowns & Recovery
As of October 16, 2026, CRM's worst peak-to-trough fall over the last 10 years with dividends reinvested was -58.5% (November 2021 to December 2022); it regained that peak by March 2024, 15 months after the low, and 69% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CRM in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: CRM trailed the S&P 500 over this period: $34,523 against $42,525.
A $10,000 investment in CRM in October 2016 would be worth about $34,523 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CRM, and which have not.
Strongest month, January: an average of +6.70%, up in 8 of 10 years.
Weakest month, December: an average of -2.68%, up in 3 of 10 years.
This month, October: has averaged +2.65%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CRM's strongest calendar month has been January (average +6.70%, up in 8 of 10 years) and its weakest December (average -2.68%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CRM, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CRM today could grow to about $23,022 by 2036 in the base case, with a 90th-percentile outcome near $100,227 and a 10th-percentile outcome around $5,288. The simulation models price only; at today's 0.72% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
CRM Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $336 for CRM by 2030 in the base case, from $241 today (1.4x over 4 years). The 10th-percentile path ends near $133. These are outcomes of a Monte Carlo simulation run on CRM's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $164 | $262 | $417 | |
| 2028 | $147 | $284 | $549 | |
| 2029 | $138 | $309 | $692 | |
| 2030 | $133 | $336 | $852 | |
| 2031 | $129 | $365 | $1,033 |
Method: a lognormal simulation of CRM's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
CRM insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $28.4M on the open market and sold $88.8M.
As of October 16, 2026, CRM insiders reported 104 open-market sales worth $88.8M and 6 open-market purchases worth $28.4M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | G Parker Harris
Officer and Director
|
Grant | 2.5K | - |
| Sep 22, 2026 | Miguel Milano
President
|
Grant | 2.5K | - |
| Sep 22, 2026 | Sabastian Niles
President
|
Grant | 2.0K | - |
| Sep 22, 2026 | Robin L Washington
President
|
Grant | 1.8K | - |
| Sep 18, 2026 | David Blair Kirk
Director
|
Buy | 4.2K | $999.5K |
| Sep 4, 2026 | Craig Conway
Director
|
Sell | 4.5K | $1.2M |
| Aug 28, 2026 | G Parker Harris
Officer and Director
|
Grant | 16.0K | - |
| Aug 21, 2026 | Laura Alber
Director
|
Grant | 441 | - |
| Aug 21, 2026 | Amy L Chang
Director
|
Grant | 441 | - |
| Aug 21, 2026 | Craig Conway
Director
|
Grant | 441 | - |
| Aug 21, 2026 | Arnold Wayne Donald
Director
|
Grant | 441 | - |
| Aug 21, 2026 | David Blair Kirk
Director
|
Grant | 441 | - |
| Aug 21, 2026 | Neelie Kroes
Director
|
Grant | 441 | - |
| Aug 21, 2026 | Miguel Milano
President
|
Grant | 1.7K | - |
| Aug 21, 2026 | Oscar X Munoz
Director
|
Grant | 441 | - |
| Aug 21, 2026 | Sabastian Niles
President
|
Grant | 1.7K | - |
| Aug 21, 2026 | John Victor Roos
Director
|
Grant | 441 | - |
| Aug 21, 2026 | J. Mehra Sachin
Director
|
Grant | 441 | - |
| Jul 22, 2026 | G Parker Harris
Officer and Director
|
Grant | 1.8K | - |
| Jul 22, 2026 | Srinivas D. Tallapragada
Officer
|
Grant | 1.8K | - |
| Jun 22, 2026 | G Parker Harris
Officer and Director
|
Grant | 2.5K | - |
| Jun 22, 2026 | Miguel Milano
Chief Executive Officer
|
Grant | 2.5K | - |
| Jun 22, 2026 | Sabastian Niles
President
|
Grant | 2.0K | - |
| Jun 22, 2026 | Srinivas D. Tallapragada
Officer
|
Grant | 3.4K | - |
| Jun 22, 2026 | Robin L Washington
President
|
Grant | 1.8K | - |
| May 22, 2026 | Laura Alber
Director
|
Grant | 442 | - |
| May 22, 2026 | Amy L Chang
Director
|
Grant | 442 | - |
| May 22, 2026 | Craig Conway
Director
|
Grant | 442 | - |
| May 22, 2026 | Arnold Wayne Donald
Director
|
Grant | 442 | - |
| May 22, 2026 | David Blair Kirk
Director
|
Grant | 442 | - |
| May 22, 2026 | Neelie Kroes
Director
|
Grant | 442 | - |
| May 22, 2026 | Miguel Milano
President
|
Grant | 1.7K | - |
| May 22, 2026 | Oscar X Munoz
Director
|
Grant | 442 | - |
| May 22, 2026 | Sabastian Niles
Chief Executive Officer
|
Grant | 1.7K | - |
| May 22, 2026 | John Victor Roos
Director
|
Grant | 442 | - |
| May 22, 2026 | J. Mehra Sachin
Director
|
Grant | 442 | - |
| Apr 22, 2026 | G Parker Harris
Officer and Director
|
Grant | 1.8K | - |
| Apr 22, 2026 | Srinivas D. Tallapragada
Officer
|
Grant | 1.8K | - |
| Mar 20, 2026 | Marc Russell Benioff
Chief Executive Officer
|
Grant | 45.5K | - |
| Mar 20, 2026 | G Parker Harris
Officer and Director
|
Grant | 27.8K | - |
| Mar 20, 2026 | G Parker Harris
Officer and Director
|
Grant | 7.4K | - |
| Mar 20, 2026 | Miguel Milano
President
|
Grant | 7.1K | - |
| Mar 20, 2026 | Miguel Milano
President
|
Grant | 16.1K | - |
| Mar 20, 2026 | Sabastian Niles
President
|
Grant | 16.1K | - |
| Mar 20, 2026 | Sabastian Niles
President
|
Grant | 5.1K | - |
| Mar 20, 2026 | Srinivas D. Tallapragada
Officer
|
Grant | 9.8K | - |
| Mar 20, 2026 | Srinivas D. Tallapragada
Officer
|
Grant | 27.8K | - |
| Mar 20, 2026 | Robin L Washington
President
|
Grant | 7.3K | - |
| Mar 19, 2026 | Laura Alber
Director
|
Buy | 2.6K | $500.3K |
| Mar 18, 2026 | David Blair Kirk
Director
|
Buy | 2.6K | $500.2K |
| Feb 20, 2026 | Laura Alber
Director
|
Grant | 442 | - |
| Feb 20, 2026 | Amy L Chang
Director
|
Grant | 442 | - |
| Feb 20, 2026 | Craig Conway
Director
|
Grant | 442 | - |
| Feb 20, 2026 | Arnold Wayne Donald
Director
|
Grant | 442 | - |
| Feb 20, 2026 | David Blair Kirk
Director
|
Grant | 442 | - |
| Feb 20, 2026 | Neelie Kroes
Director
|
Grant | 442 | - |
| Feb 20, 2026 | Miguel Milano
President
|
Grant | 1.7K | - |
| Feb 20, 2026 | Oscar X Munoz
Director
|
Grant | 442 | - |
| Feb 20, 2026 | Sabastian Niles
President
|
Grant | 1.7K | - |
| Feb 20, 2026 | John Victor Roos
Director
|
Grant | 442 | - |
| Feb 20, 2026 | J. Mehra Sachin
Director
|
Grant | 442 | - |
| Feb 20, 2026 | Maynard George Webb Jr
Director
|
Grant | 442 | - |
| Jan 22, 2026 | G Parker Harris
Officer and Director
|
Grant | 1.8K | - |
| Jan 22, 2026 | Sundeep G Reddy
Officer
|
Grant | 487 | - |
| Jan 22, 2026 | Srinivas D. Tallapragada
Officer
|
Grant | 1.8K | - |
| Jan 14, 2026 | Neelie Kroes
Director
|
Sell | 3.9K | $929.3K |
| Jan 13, 2026 | Marc Russell Benioff
Chief Executive Officer
|
Option | 1 | $215 |
| Dec 22, 2025 | G Parker Harris
Officer and Director
|
Grant | 2.3K | - |
| Dec 22, 2025 | Miguel Milano
President
|
Grant | 1.0K | - |
| Dec 22, 2025 | Sabastian Niles
President
|
Grant | 1.0K | - |
| Dec 22, 2025 | Sundeep G Reddy
Officer
|
Grant | 574 | - |
| Dec 22, 2025 | Srinivas D. Tallapragada
Officer
|
Grant | 2.5K | - |
| Dec 17, 2025 | David Blair Kirk
Director
|
Buy | 1.9K | $500.7K |
| Dec 5, 2025 | G Mason Morfit
Director and Beneficial Owner of more than 10% of a Class of Security
|
Buy | 96.0K | $25.0M |
| Dec 2, 2025 | G Parker Harris
Officer and Director
|
Sell | 134.7K | $31.6M |
| Dec 2, 2025 | G Parker Harris
Officer and Director
|
Option | 134.7K | $21.7M |
| Nov 21, 2025 | Laura Alber
Director
|
Grant | 274 | - |
| Nov 21, 2025 | Amy L Chang
Director
|
Grant | 424 | - |
| Nov 21, 2025 | Craig Conway
Director
|
Grant | 274 | - |
| Nov 21, 2025 | Arnold Wayne Donald
Director
|
Grant | 274 | - |
| Nov 21, 2025 | David Blair Kirk
Director
|
Grant | 424 | - |
| Nov 21, 2025 | Neelie Kroes
Director
|
Grant | 274 | - |
| Nov 21, 2025 | Miguel Milano
President
|
Grant | 1.7K | - |
| Nov 21, 2025 | Oscar X Munoz
Director
|
Grant | 274 | - |
| Nov 21, 2025 | Sabastian Niles
President
|
Grant | 1.7K | - |
| Nov 21, 2025 | John Victor Roos
Director
|
Grant | 274 | - |
| Nov 21, 2025 | J. Mehra Sachin
Director
|
Grant | 274 | - |
| Nov 21, 2025 | Maynard George Webb Jr
Director
|
Grant | 274 | - |
| Nov 3, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 122 | $31.6K |
| Nov 3, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 122 | $19.7K |
| Oct 31, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $580.9K |
| Oct 31, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 30, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $577.8K |
| Oct 30, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 29, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $567.1K |
| Oct 29, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 28, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $578.4K |
| Oct 28, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 27, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $576.3K |
| Oct 27, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 24, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $575.0K |
| Oct 24, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 23, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $575.1K |
| Oct 23, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 22, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $582.8K |
| Oct 22, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 22, 2025 | G Parker Harris
Officer and Director
|
Grant | 1.8K | - |
| Oct 22, 2025 | Sundeep G Reddy
Officer
|
Grant | 910 | - |
| Oct 22, 2025 | Srinivas D. Tallapragada
Officer
|
Grant | 1.8K | - |
| Oct 21, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $590.1K |
| Oct 21, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 20, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $567.6K |
| Oct 20, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 17, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $550.4K |
| Oct 17, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 16, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $558.8K |
| Oct 16, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 15, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $536.3K |
| Oct 15, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Option | 2.3K | $363.4K |
| Oct 14, 2025 | Marc Russell Benioff
Chief Executive Officer
|
Sell | 2.3K | $548.8K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.